Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone

DT Lysle, ME Coussons, VJ Watts, EH Bennett and LA Dykstra

Department of Psychology, University of North Carolina, Chapel Hill.

Although there is evidence to suggest that morphine can alter immune status, there is little information about the doses at which these effects occur, the extent of the immune alterations and whether morphine's immunomodulatory effects can be antagonized in a dose- dependent manner by an opioid antagonist. To address these issues, morphine (0, 5.0, 10.0, 15.0 or 25.0 mg/kg) was administered s.c. to Lewis rats. One hr later, the spleen, mesenteric lymph nodes and a sample of peripheral blood were collected. Immune status was assessed by a variety of in vitro assays. For splenic lymphocytes, morphine induced a dose-dependent suppression of lymphocyte function as measured by mitogen-induced proliferation, natural killer cell cytotoxicity, interleukin-2 production and interferon production. For blood lymphocytes, the mitogen-induced proliferative response was suppressed in a dose-dependent manner. In contrast, morphine did not alter the capability of lymphocytes in the mesenteric lymph nodes to proliferate or produce cytokines. In a separate study, naltrexone (0, 0.1, 1.0 or 10.0 mg/kg) was administered before the injection of morphine (15 mg/kg). The results show that the immunomodulatory effects of morphine are antagonized by naltrexone. Collectively, the results of this investigation show that morphine's immunomodulatory effects are dose dependent, compartment specific and antagonized by naltrexone.

Volume 265, Issue 3, pp. 1071-1078, 06/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				T. B. Saurer, S. G. Ijames, and D. T. Lysle Evidence for the Nucleus Accumbens as a Neural Substrate of Heroin-Induced Immune Alterations J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1040 - 1047. [Abstract] [Full Text] [PDF]

				M.-P. Bonnet, H. Beloeil, D. Benhamou, J.-X. Mazoit, and K. Asehnoune The {micro} Opioid Receptor Mediates Morphine-Induced Tumor Necrosis Factor and Interleukin-6 Inhibition in Toll-Like Receptor 2-Stimulated Monocytes Anesth. Analg., April 1, 2008; 106(4): 1142 - 1149. [Abstract] [Full Text] [PDF]

				K. Benamar, M. Yondorf, V. T. Barreto, E. B. Geller, and M. W. Adler Deletion of {micro}-Opioid Receptor in Mice Alters the Development of Acute Neuroinflammation J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 990 - 994. [Abstract] [Full Text] [PDF]

				L. Qian, K. S. Tan, S.-J. Wei, H.-M. Wu, Z. Xu, B. Wilson, R.-B. Lu, J.-S. Hong, and P. M. Flood Microglia-Mediated Neurotoxicity Is Inhibited by Morphine through an Opioid Receptor-Independent Reduction of NADPH Oxidase Activity J. Immunol., July 15, 2007; 179(2): 1198 - 1209. [Abstract] [Full Text] [PDF]

				T. J. Murphy Simple Nuclear Factor {kappa}B-Mediated {micro}-Opioid Receptor Induction in Immune Cells Mol. Pharmacol., October 1, 2003; 64(4): 796 - 797. [Full Text] [PDF]

				H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF]

				E. Limiroli, L. Gaspani, A. E. Panerai, and P. Sacerdote Differential morphine tolerance development in the modulation of macrophage cytokine production in mice J. Leukoc. Biol., July 1, 2002; 72(1): 43 - 48. [Abstract] [Full Text] [PDF]

				M. P. Yeager, M. A. Procopio, J. A. DeLeo, J. L. Arruda, L. Hildebrandt, and A. L. Howell Intravenous Fentanyl Increases Natural Killer Cell Cytotoxicity and Circulating CD16+ Lymphocytes in Humans Anesth. Analg., January 1, 2002; 94(1): 94 - 99. [Abstract] [Full Text] [PDF]

				J. Wang, R. Charboneau, S. Balasubramanian, R. A. Barke, H. H. Loh, and S. Roy Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide J. Leukoc. Biol., October 1, 2001; 70(4): 527 - 536. [Abstract] [Full Text] [PDF]

				X. Peng, J. J. Cebra, M. W. Adler, J. J. Meissler Jr., A. Cowan, P. Feng, and T. K. Eisenstein Morphine Inhibits Mucosal Antibody Responses and TGF-{beta} mRNA in Gut-Associated Lymphoid Tissue Following Oral Cholera Toxin in Mice J. Immunol., October 1, 2001; 167(7): 3677 - 3681. [Abstract] [Full Text] [PDF]

				M. A. Wetzel, A. D. Steele, T. K. Eisenstein, M. W. Adler, E. E. Henderson, and T. J. Rogers {micro}-Opioid Induction of Monocyte Chemoattractant Protein-1, RANTES, and IFN-{gamma}-Inducible Protein-10 Expression in Human Peripheral Blood Mononuclear Cells J. Immunol., December 1, 2000; 165(11): 6519 - 6524. [Abstract] [Full Text] [PDF]

				X. Peng, D. M. Mosser, M. W. Adler, T. J. Rogers, J. J. Meissler Jr, and T. K. Eisenstein Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages J. Leukoc. Biol., November 1, 2000; 68(5): 723 - 728. [Abstract] [Full Text]

				J. E. Nowak, R. Gomez-Flores, S. N. Calderon, K. C. Rice, and R. J. Weber Rat Natural Killer Cell, T Cell and Macrophage Functions after Intracerebroventricular Injection of SNC 80 J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 931 - 937. [Abstract] [Full Text]

				C. Gaveriaux-Ruff, H. W. D. Matthes, J. Peluso, and B. L. Kieffer Abolition of morphine-immunosuppression in mice lacking the µ-opioid receptor gene PNAS, May 26, 1998; 95(11): 6326 - 6330. [Abstract] [Full Text] [PDF]